Patent · US Active

Methods and compositions for genome engineering

US10968261B2 · kind B2 · utility

2Cited by
50References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 21, 2018
Grant dateApr 6, 2021
Priority date
Expiry dateNov 16, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2750/14143
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are methods and compositions for insertion of transgene sequences encoding proteins that is aberrantly expressed in disease or disorder such as a lysosomal storage disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.